~~<i id='F36B50B13E'><strike id='F36B50B13E'><tt id='F36B50B13E'><pre id='F36B50B13E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：comprehensive 2025-09-30 01:14:36 - browse：34

Bruce Broussard. -- health business coverage from STAT — Humana CEO Bruce Broussard Jason DeCrow/AP

Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

Humana’s stock fell by more than 2% on the news Wednesday morning.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： First Opinion Podcast: How to protect health care in times of war

focus

Wikipedia

explore

focus

knowledge

entertainment

MollyFerguson/STATCassavaScienceshaslongclaimeditsexperimentaldrug,calledsimufilam,slowsthecognitive

WSS

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Traditional Chinese medicine benefits explored in new JAMA study

Alabama IVF ruling threatens families facing fatal genetic disease

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Medicare inequities exacerbate Puerto Rico’s health disparities

Physician subsidies by hospitals soar in wake of No Surprises Act

hotspot

fashion

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Paying for Covid pills will soon shift to insurers

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare inequities exacerbate Puerto Rico’s health disparities

In age of alternative facts, a scholarly course on calling out crap

The Harvard botanist who searched for psychedelics in the Amazon

Drug repurposing or repositioning? The language matters

The FDA weighs the risks of candy

Bright Health sells Medicare Advantage business to Molina

Diversifying clinical trials isn't enough to close racial gaps: study

Wikipedia

PBM reform efforts get punted in Congress

Dario to buy mental health app maker Twill in cash and stock deal

Medicare inequities exacerbate Puerto Rico’s health disparities

Cassava reveals details — and problems — with Alzheimer's study

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Alabama frozen embryo ruling has major implications for IVF clinics

explore

focus

knowledge

entertainment